Eran Broshy - May 2, 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role: Director
Signature: /s/ Brett A. Grimaud, Attorney-in-Fact
Stock symbol: TBPH
Transactions as of: May 2, 2023
Transactions value $: $0
Form type: 4
Date filed: 5/4/2023, 06:36 PM
Previous filing: Jul 15, 2022
Next filing: May 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TBPH	Ordinary Shares	Award	$0	+9.13K	+15%	$0.00	70K	May 2, 2023	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TBPH	Share Option (Right to Buy)	Award	$0	+22K		$0.00	22K	May 2, 2023	Ordinary Shares	22K	$10.95	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This option may be exercised and shall be vested as to 1/12th of the shares subject to this option when optionee completes each continuous month of service following the grant date and any then remaining unvested shares shall vest on the date of the next annual meeting of the company's shareholders provided the optionee remains in continuous service on such date.